Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesEndocrinologyCurative Adrenalectomy Coverage Update | OpenPayer
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    CurrentCurativePolicy CHP-IP-2026-245

    Adrenalectomy for Pheochromocytoma and Abdominal Paraganglioma

    Customize your policy alerts

    Sign up for curative Policy CHP-IP-2026-245 alerts

    Get alerted when Policy CHP-IP-2026-245 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs medical necessity, inpatient level of care, continued-stay review, discharge readiness, documentation, and coding for laparoscopic, robotic, or open adrenalectomy for pheochromocytoma and resection of abdominal paraganglioma in adults and children.

    Policy Summary
    PayerCurative
    PolicyAdrenalectomy for Pheochromocytoma and Abdominal Paraganglioma
    Policy CodePolicy CHP-IP-2026-245
    Change TypeNo material change
    Effective DateN/A
    Next Review DateN/A
    Key ActionDocument preoperative alpha blockade, including the agent, start date, and blood-pressure and heart-rate response.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    7-14 daysPreoperative alpha blockade
    24-48 hoursImmediate postoperative monitoring
    1-3 daysLaparoscopic stay
    3-5 daysOpen resection stay
    4Extended-stay triggers

    Inpatient Coverage Criteria

    Observation or outpatient instead of inpatient

    There is no outpatient or observation pathway for pheochromocytoma resection.

    Preoperative services: Preoperative alpha blockade and titration are outpatient unless severe hypertension or orthostatic symptoms require inpatient titration; biochemical testing and imaging are outpatient services.

    A preoperative admission is appropriate only when outpatient blockade cannot be achieved safely.

    Intensive care unit

    ICU placement is appropriate when ANY of the following is present.

    ICU level of care

    • Airway or ventilation: Invasive mechanical ventilation or a new or unstable artificial airway requiring continuous critical-care airway expertise.
    • Hemodynamic instability: Systolic blood pressure below 90 mm Hg or mean arterial pressure below 65 mm Hg persisting after initial fluid resuscitation, or any titrated vasopressor or inotrope infusion.SBP <90 mm Hg or MAP <65 mm Hg
    • Hemorrhage or coagulopathy: Ongoing hemorrhage needing repeated transfusion, massive transfusion protocol activation, or coagulopathy correction with frequent laboratory titration.
    • Acute respiratory failure: SpO2 below 90% despite FiO2 of 0.5 or more, escalating high-flow or noninvasive ventilation, or respiratory rate above 30/min with increased work of breathing.SpO2 <90%; FiO2 >=0.5; RR >30/min
    • Neurologic instability: Glasgow Coma Scale 8 or less, a fall of 2 or more points, a new focal neurologic deficit, or seizures needing intravenous antiseizure titration.GCS <=8 or decrease >=2 points
    • Frequent nursing intervention: Nursing assessment and intervention needed every hour or more often, exceeding step-down staffing.Every hour or more often
    • Post-resection hemodynamic crisis: Post-resection hypotension needing vasopressors or large-volume fluid resuscitation, or hypertensive crisis needing titrated intravenous infusion.
    • Cardiac instability: Sustained arrhythmia or catecholamine cardiomyopathy.

    Step-down or intermediate care

    Step-down or intermediate care is appropriate when the patient does not meet ICU criteria and ANY of the following is present.

    • Frequent assessment: Vital-sign or focused assessments every 2 hours, or hourly for a limited protocol-defined period, exceeding medical-surgical capability.Every 2 hours or hourly for a limited period
    • Continuous monitoring or respiratory support: Continuous cardiac telemetry or pulse oximetry for documented arrhythmia, ischemia, or respiratory risk, or stable noninvasive or high-flow respiratory support.
    • Monitored infusions: Non-titrated or slowly titrated infusions needing frequent monitoring.

      Examples include insulin, heparin, or a weaning antihypertensive infusion.

    Medical-surgical unit

    A medical-surgical unit is appropriate when the patient does not meet ICU or step-down criteria and ANY of the following is present.

    Medical-surgical level of care

    • Stable without vasoactive infusions: Hemodynamically stable off vasoactive infusions for at least 12 to 24 hours, with vital signs every 4 hours or less often clinically adequate.Off vasoactive infusions for 12 to 24 hours
    • Ongoing hospital-level services: Intravenous medications or fluids, parenteral analgesia, drain or wound care beyond home capability, or daily surgical reassessment remains necessary.
    • Stable recovery transition: Stable hemodynamics off infusions, glucose stable, diet advancing, and analgesia transition underway.

    Discharge readiness

    Discharge readiness requires ALL of the following.

    • Physiologic stability: Temperature below 38.0 C for at least 24 hours without antipyretic masking, heart rate below 100/min, systolic blood pressure at least 90 mm Hg or documented baseline, and SpO2 at least 92% on room air or baseline home oxygen.T <38.0 C; HR <100/min; SBP >=90 mm Hg or baseline; SpO2 >=92%
    • Pain controlled on an oral or other home-deliverable regimen.
    • Nutrition: Oral diet tolerated, or stable enteral or parenteral nutrition plan with supplies and caregiver teaching completed.
    • Laboratory stability: Hemoglobin stable without transfusion for 24 hours and electrolytes and renal function acceptable or covered by an outpatient monitoring plan.

    Continued acute inpatient stay

    Continued acute inpatient care is medically necessary when ANY of the following is documented; review occurs every 24 hours in ICU or step-down and every 24 to 48 hours on a medical-surgical unit.

    Continued-stay criteria

    • Persistent hemodynamic instability: Hypotension or hypertension needing infusion or frequent titration beyond 48 hours.>48 hours
    • Recurrent hypoglycemia needing intravenous dextrose.
    • Adrenal insufficiency or complication: Adrenal insufficiency being stabilized, or surgical complication such as bleeding or pancreatic or splenic injury.
    • Unmet discharge readiness: Discharge-readiness criteria are not met because of a documented, actively treated clinical problem.

    This policy applies to inpatient laparoscopic, robotic, or open adrenalectomy, including cortical-sparing adrenalectomy, for pheochromocytoma, and to abdominal paraganglioma resection when coded with the applicable procedures. Adrenalectomy for other adrenal tumors is outside this policy and is reviewed under the general surgical policy.

    There is no outpatient or observation pathway for pheochromocytoma resection. Preoperative alpha-adrenergic blockade, titration, biochemical testing, and imaging are generally performed as outpatient services; a preoperative admission is appropriate only when blockade cannot be achieved safely as an outpatient, such as with severe hypertension or orthostatic symptoms.

    Elective pheochromocytoma resection without documented preoperative alpha-adrenergic blockade, and without an urgent indication, is not medically necessary as scheduled. The request is referred for physician review because inadequate preparation increases the risk of intraoperative hemodynamic instability.

    A continued acute inpatient stay after all discharge-readiness criteria have been met is not medically necessary at the acute level. Such days are considered custodial or provided for convenience rather than for an active acute clinical need.

    A continued stay solely while awaiting post-acute placement, transportation, or caregiver availability does not meet acute criteria when there is no active acute need. The case is routed to physician review and discharge planning.

    A stay beyond the expected length-of-stay benchmark does not meet continued-stay criteria as documented unless a specific extended-stay trigger is identified and supported by clinical information. Missing information should be requested before physician review.

    Coding and Operational Thresholds

    ICD-10-CM diagnosesICD-10
    E27.5Adrenomedullary hyperfunction
    D35.00Benign neoplasm of unspecified adrenal gland
    D35.01Benign neoplasm of right adrenal gland
    D35.02Benign neoplasm of left adrenal gland
    C74.10Malignant neoplasm of unspecified adrenal medulla
    C74.11Malignant neoplasm of right adrenal medulla
    C74.12Malignant neoplasm of left adrenal medulla
    ICD-10-PCS proceduresICD-10
    0GT20ZZResection of left adrenal gland, open approach
    0GT24ZZResection of left adrenal gland, percutaneous endoscopic approach
    0GT30ZZResection of right adrenal gland, open approach
    0GT34ZZResection of right adrenal gland, percutaneous endoscopic approach
    0GT40ZZResection of bilateral adrenal glands, open approach
    0GT44ZZResection of bilateral adrenal glands, percutaneous endoscopic approach
    CPT adrenalectomy proceduresCPT
    60540Adrenalectomy, open
    60545Adrenalectomy, open with adjacent retroperitoneal tumor
    60650Adrenalectomy, laparoscopic
    MS-DRG FY2027 v44mixed
    614Adrenal and pituitary procedures with CC/MCC
    615Adrenal and pituitary procedures without CC/MCC
    Revenue codesRevenue
    0110Room and board
    0111Room and board
    0112Room and board
    0113Room and board
    0114Room and board
    0115Room and board
    0116Room and board
    0117Room and board
    0118Room and board
    0119Room and board
    1–10 of 35
    1/4
    Large tumor
    Large tumor thresholdOver about 6 cm
    Surgical approachOpen adrenalectomy
    Other qualifying proceduresBilateral or cortical-sparing resection
    ICU hypotension threshold
    Systolic blood pressureBelow 90 mm Hg
    Mean arterial pressureBelow 65 mm Hg

    Documentation and Review Requirements

    Documentation Required

    Operative Indication and Decision

    Document the operative indication, including the diagnosis, staging or relevant imaging, and the surgical or multidisciplinary decision supporting the procedure.

    • Diagnosis and operative indication
    • Staging or imaging findings
    • Surgical or multidisciplinary decision
    Documentation Required

    Preoperative Risk Assessment

    Record the preoperative risk assessment, including the ASA physical status classification and relevant comorbidities that may affect perioperative management.

    • ASA physical status class
    • Relevant comorbidities
    • Perioperative risk considerations

    Clinical Background

    Pheochromocytomas secrete catecholamines, which can cause severe intraoperative hypertension and arrhythmia. After tumor resection, patients may instead develop hypotension and hypoglycemia, making postoperative monitoring of blood pressure, heart rate, and glucose clinically important.

    Key Definitions

    Alpha-adrenergic blockade
    DefinitionPreoperative treatment with a selective or nonselective alpha blocker
    Beta-blocker sequencingAdd beta blockade only after alpha blockade when needed for tachycardia
    Treatment purposeControl catecholamine-related tachycardia after alpha blockade
    Policy Summary
    PayerCurative
    PolicyAdrenalectomy for Pheochromocytoma and Abdominal Paraganglioma
    Policy CodePolicy CHP-IP-2026-245
    Change TypeNo material change
    Effective DateN/A
    Next Review DateN/A
    Key ActionDocument preoperative alpha blockade, including the agent, start date, and blood-pressure and heart-rate response.
    SourceLink
    On This Page
    Inpatient Coverage CriteriaCoding and Operational ThresholdsDocumentation and Review RequirementsClinical BackgroundKey Definitions
    Post-ICU monitoring:
    First 24 hours after transfer out of ICU when closer monitoring than a medical-surgical unit provides remains necessary.
    24 hours
  1. Early post-resection monitoring: Blood pressure and heart rate every 1 to 2 hours with glucose checks every 1 to 4 hours during the first 24 hours after resection.BP/HR every 1-2 hours; glucose every 1-4 hours
  2. No transfusion for 24 hours
  3. Wound and drains: Wound stable; drains removed or output acceptable with documented home drain teaching.
  4. Mobility and post-acute needs: Mobility at expected post-procedure level, or an appropriate post-acute level of care arranged for documented functional needs.
  5. Safe transition plan: Medications reconciled; VTE prophylaxis plan established by risk; surgeon follow-up within 7 to 14 days; wound-care and return-precaution education completed; and home health or durable medical equipment arranged when needed.Follow-up within 7 to 14 days
  6. Blood pressure and adrenal medication plan: Blood pressure and heart rate stable without orthostatic symptoms, and alpha blocker stopped or adjusted.
  7. Glucose stability: Glucose stable without hypoglycemia for at least 24 hours.24 hours
  8. Adrenal insufficiency management: Adrenal insufficiency excluded or treated after bilateral or cortical-sparing resection, with steroid education.
  9. Follow-up testing and genetics: Follow-up plasma or urine metanephrines and genetic counseling planned.Metanephrines about 2 to 6 weeks after surgery
  10. Necessary upcoming intervention: A medically necessary procedure or intervention is scheduled within the next 24 hours and cannot safely be performed outpatient.Within 24 hours
  11. Required context
    Threshold persists after initial fluid resuscitation; a titrated vasopressor or inotrope infusion also supports ICU placement
    Acute respiratory failure oxygen threshold
    Oxygen saturationSpO2 below 90%
    Inspired oxygen thresholdDespite FiO2 of 0.5 or more
    Additional respiratory criteriaEscalating high-flow or noninvasive ventilation, or respiratory rate above 30/min with increased work of breathing
    Neurologic ICU threshold
    Glasgow Coma Scale8 or less
    Neurologic declineFall of 2 or more points
    Other neurologic instabilityNew focal neurologic deficit or seizures requiring intravenous antiseizure titration
    Early postoperative monitoring
    Blood pressure and heart rateMonitor every 1 to 2 hours
    GlucoseCheck every 1 to 4 hours
    Monitoring periodDuring the first 24 hours after resection
    Discharge physiologic stability
    TemperatureBelow 38.0 C for at least 24 hours without antipyretic masking
    Heart rateBelow 100/min
    Blood pressureSystolic blood pressure at least 90 mm Hg or at documented baseline
    Oxygen saturationSpO2 at least 92% on room air or baseline home oxygen
    Postoperative glucose stability
    Glucose statusStable without hypoglycemia
    Required durationAt least 24 hours
    Discharge requirementGlucose stability is required before discharge
    Post-resection hypoglycemia red flag
    Red-flag thresholdGlucose below 70 mg/dL after resection
    Required responseTreat hypoglycemia
    Monitoring responseIncrease glucose monitoring frequency
    Documentation Required

    Procedure and Planned Level of Care

    Document the planned procedure or procedures, applicable CPT and ICD-10-PCS codes, the planned postoperative level of care, and the clinical reason for that level of care.

    • Planned procedure(s)
    • CPT and ICD-10-PCS codes
    • Planned postoperative level of care and rationale
    Documentation Required

    Daily Acute-Care Documentation

    Provide daily progress notes that identify the active acute problem, the hospital-level service delivered, and the treatment plan for continued acute care.

    • Active acute problem
    • Hospital-level service delivered
    • Current treatment plan
    Documentation Required

    Clinical Monitoring Records

    Maintain clinical monitoring records supporting the requested level of care, including vital signs, intake and output, relevant laboratory results, and procedure-specific monitoring.

    • Vital signs
    • Intake and output
    • Relevant laboratory results
    • Procedure-specific monitoring records
    Documentation Required

    Extended-Stay Evidence

    For any stay beyond the expected length of stay, document the specific extended-stay trigger and the supporting clinical evidence.

    • Specific extended-stay trigger
    • Supporting evidence
    • Link between the trigger and continued acute care
    Documentation Required

    Discharge and Transition Plan

    Document the discharge readiness assessment and transition plan, including follow-up, patient education, and required post-acute services.

    • Discharge readiness criteria
    • Follow-up plan
    • Patient and caregiver education
    • Post-acute services
    Documentation Required

    Pheochromocytoma-Specific Records

    For pheochromocytoma or paraganglioma cases, include disease-specific records supporting diagnosis, preparation, and postoperative management.

    • Metanephrine results and imaging
    • Alpha-blockade agent, start date, and blood pressure and heart rate response
    • Postoperative blood pressure, heart rate, and glucose records
    Billing Rule

    Documentation Must Support Requested Amount

    Support the full requested quantity, units, or duration with documentation. If only part of the request is supported, the unsupported increment may be reviewed separately.

    • Document the requested quantity, units, or duration
    • Support each requested increment with clinical documentation
    • The supported portion may be approved while only the unsupported increment is reviewed
    Denial Risk

    Missing Preoperative Alpha Blockade

    Elective resection without documented preoperative alpha-adrenergic blockade, absent an urgent indication, does not meet medical-necessity criteria and is referred for physician review.

    • Document the alpha-adrenergic blockade before elective resection
    • Include the agent, start date, and response when applicable
    • Urgent indications must be documented if blockade is absent
    Denial Risk

    Stay After Discharge Readiness

    Continued acute inpatient care after all discharge readiness criteria are met does not meet acute-level medical-necessity criteria. A documented, actively treated clinical problem must support any additional stay.

    • Document the remaining unmet discharge-readiness criterion
    • Identify the actively treated clinical problem supporting continued care
    • Days after readiness may be considered custodial or for convenience
    Denial Risk

    Nonclinical Discharge Delay

    A stay solely awaiting post-acute placement, transportation, or caregiver availability does not support continued acute care when there is no active acute need.

    • Document any active acute need separately from the logistical delay
    • Route the case to physician review and discharge planning
    • This circumstance is not a basis for retroactive denial of days already authorized
    Denial Risk

    Unsupported Extended Stay

    A stay beyond the expected length of stay requires documentation of a specific extended-stay trigger and supporting clinical evidence. The expected length of stay is a planning benchmark, not an automatic limit on covered days.

    • Identify the applicable continued-stay criterion
    • Document the trigger and supporting evidence
    • Request missing clinical information and refer for physician review when the record is insufficient
    Documentation Required

    Continued-Stay Support

    Continued acute inpatient care is medically necessary when at least one qualifying condition is documented and actively supports the acute level of care. Continued-stay review occurs every 24 hours in intensive or step-down care and every 24 to 48 hours on a medical-surgical unit.

    • Hemodynamic instability requiring infusion or frequent titration beyond 48 hours
    • Recurrent hypoglycemia requiring intravenous dextrose
    • Adrenal insufficiency being stabilized or a surgical complication such as bleeding or pancreatic or splenic injury
    • Discharge readiness criteria are not met because of a documented, actively treated clinical problem
    • A medically necessary procedure or intervention is scheduled within 24 hours and cannot safely be performed outpatient
    Billing Rule

    Adverse Determination Requires Physician Review

    An adverse determination may be issued only after physician review by a licensed physician of the same or similar specialty, with an opportunity for the requesting provider to participate in a peer-to-peer discussion.

    • Automated systems and non-physician reviewers may approve in full or in part but may not issue an adverse determination
    • Reviewing physician must meet applicable licensure, specialty, and medical-director requirements
    • Requests that do not meet criteria are referred for physician review
    Billing Rule

    Unsupported Increment May Be Adverse

    When the service meets criteria but the requested quantity, units, or duration exceed what the documentation supports, approve the supported portion and subject only the unsupported increment to review.

    • Separate the supported amount from the unsupported increment
    • Do not treat the entire request as unsupported when only part exceeds the documentation
    • Concurrent review applies to each continued-stay period; days already authorized are not retroactively denied